Cover Image

Refractory wound healing and cytopenias treated with a sodium-glucose cotransporter-2 inhibitor in a patient with glucose-6-phosphatase catalytic subunit 3 deficiency

Saved in:

Bibliographic Details
Main Authors:	Louis Marois, MD, PhD (Author), Caridad Le Gal, MD (Author), Guilhem Cros, MD (Author), Emilia Liana Falcone, MD, PhD (Author), Hugo Chapdelaine, MD (Author)
Format:	Book
Published:	Elsevier, 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparing the efficacy of apple peels and a sodium-glucose cotransporter 2 inhibitor (ipragliflozin) on interstitial glucose levels: A pilot case study
by: Junichi Okada, MD, PhD, et al.
Published: (2020)

Acquired erythropoietic uroporphyria associated with clonal cytopenia of undetermined significance
by: Leah A. Swanson, MD, et al.
Published: (2023)

The Mediator complex kinase module is necessary for fructose regulation of liver glycogen levels through induction of glucose-6-phosphatase catalytic subunit (G6pc)
by: Dou Yeon Youn, et al.
Published: (2021)

Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
by: Daniel A. Kelmenson MD, et al.
Published: (2017)

USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS BY CARDIOLOGISTS SINCE THE RELEASE OF 2022 AHA/ACC/HFSA GUIDELINES FOR THE MANAGEMENT OF HEART FAILURE
by: Gowtham R. Grandhi, MD MPH, et al.
Published: (2023)

Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure
by: Ya-Wen Lin PhD, RN, et al.
Published: (2024)

Evaluation of Phosphorylated Urinary Na-Cl Cotransporter Is Potentially Useful in a Patient With Pseudohypoaldosteronism Type II due to Mutation in
by: Keiko Nagahara MD, PhD, et al.
Published: (2014)

Differences in the effects of Kenyan, Tanzanian, and Ethiopian coffee intake on interstitial glucose levels measured by FreeStyle Libre: A pilot case study
by: Junichi Okada, MD, PhD, et al.
Published: (2020)

Continuous monitoring of fetal gross movement and maternal glucose level using newly developed methodsAJOG Global Reports at a Glance
by: Eiji Ryo, MD, PhD, et al.
Published: (2023)

Prevalence of Diabetes and Impaired Fasting Glucose in Chinese Adults, China National Nutrition and Health Survey, 2002
by: Shuqian Liu, MD, et al.
Published: (2011)

A New Venue for Providing Catalytic Global Communications to Promote Health and Healing
by: Remy R Coeytaux MD PhD, et al.
Published: (2017)

Simplified, Low-Cost Method on Glucose Tolerance Testing in High-Risk Group of Diabetes, Explored by Simulation of Diagnosis
by: Kan Shao MD, et al.
Published: (2022)

Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018)

Identifying Metabolic Syndrome in African American Children Using Fasting HOMA-IR in Place of Glucose
by: Sushma Sharma, PhD, et al.
Published: (2011)

LOW GLUCOSE IS A HIDDEN CARDIOVASCULAR RISK FACTOR IN APPARENTLY HEALTHY YOUNG ADULTS
by: Joshua Garza, MS, et al.
Published: (2023)

Bibliometric and visualized analysis of sodium-Glucose cotransporter 2 inhibitors
by: He Sun, et al.
Published: (2023)

Refractory cytopenia of the childhood
by: M Chowdhry, et al.
Published: (2012)

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Water and Sodium Metabolism
by: Jun Tang, et al.
Published: (2022)

Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
by: Lu Chen, et al.
Published: (2020)

The Yin and Yang Between Plasma Glucose Levels and Cortisol Replacement Therapy in Schmidt's Syndrome
by: Christopher A. Newton MD, et al.
Published: (2017)

A caveolin-1 dependent glucose-6-phosphatase trafficking contributes to hepatic glucose production
by: Amandine Gautier-Stein, et al.
Published: (2023)

Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence
by: Emir M. Muzurović MD, MM, et al.
Published: (2022)

Sodium-glucose cotransporter-2 inhibitors: A potential novel treatment for Lafora disease?
by: Paola Imbrici, et al.
Published: (2024)

Cassia Abbreviata Enhances Glucose Uptake and Glucose Transporter 4 Translocation in C2C12 Mouse Skeletal Muscle Cells
by: F. D. Y. Kamga-Simo PhD, et al.
Published: (2021)

Cassia Abbreviata Enhances Glucose Uptake and Glucose Transporter 4 Translocation in C2C12 Mouse Skeletal Muscle Cells
by: F. D. Y. Kamga-Simo PhD, et al.
Published: (2021)

Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review
by: Thahesh Tharmaraja, et al.
Published: (2022)

Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy
by: Samaneh Zandifar, et al.
Published: (2023)

Sodium-glucose cotransporter 2 inhibitors: mechanisms of cardiorenal protection: A review
by: Marina V. Leonova
Published: (2024)

Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update
by: Nicia I. Profili, et al.
Published: (2024)

Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy
by: Sanaa Bardaweel, et al.
Published: (2022)

Tanycytes release glucose using the glucose-6-phosphatase system during hypoglycemia to control hypothalamic energy balance
by: María José Barahona, et al.
Published: (2024)

The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction
by: Qian Hao PhD, et al.
Published: (2023)

Sodium/glucose cotransporter 2 and renoprotection: From the perspective of energy regulation and water conservation
by: Kento Kitada, et al.
Published: (2021)

Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects
by: Atsuo Tahara, et al.
Published: (2016)

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin
by: Sanon VP, et al.
Published: (2017)

The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction
by: Lindsay Brust-Sisti, et al.
Published: (2022)

An Overview of the Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Hematological Parameters in Diabetic Patients
by: Ghada Ahmed, et al.
Published: (2023)

Somatic genomic variants in refractory cytopenia of childhood
by: Diego F. Coutinho, et al.
Published: (2021)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
by: Moritz Mahling, et al.
Published: (2019)

Inhibition of Sodium-GlucoseCotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease
by: Daniel Rodriguez, et al.
Published: (2015)